Organon & Co
NYSE:OGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Organon & Co
NYSE:OGN
|
US |
|
Port Inc
TSE:7047
|
JP |
|
T
|
Tenet Healthcare Corp
F:THC1
|
US |
|
D
|
De' Longhi SpA
XBER:DLN
|
IT |
|
Re/Max Holdings Inc
NYSE:RMAX
|
US |
|
Komercni Banka as
LSE:0IKH
|
CZ |
|
Z
|
ZIM Integrated Shipping Services Ltd
F:2SV
|
IL |
|
I
|
Infineon Technologies AG
DUS:IFX
|
DE |
|
Establishment Labs Holdings Inc
F:3E0
|
CR |
|
N
|
Nike Inc
XMUN:NKE
|
US |
|
T
|
Terna Rete Elettrica Nazionale SpA
XMUN:UEI
|
IT |
|
S
|
SA Corporate Real Estate Fund Managers (Pty) Ltd
JSE:SAC
|
ZA |
|
S
|
Seikoh Giken Co Ltd
TSE:6834
|
JP |
|
E
|
Endesa SA
DUS:ENA
|
ES |
|
I
|
Inchcape PLC
XBER:IJCA
|
UK |
|
Qube Holdings Ltd
ASX:QUB
|
AU |
|
Flame Acquisition Corp
NYSE:SOC
|
US |
Bankruptcy Probability
Organon & Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Organon & Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Organon & Co
NYSE:OGN
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
601.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
315.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
245.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Organon & Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Organon & Co has total debt of 8.6B USD. This includes both short-term (0 USD) and long-term (8.6B USD) debt.
You can find a full breakdown on its Balance Sheet.
